Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EASEE® System Pivotal Study for the United States of America

NCT07301346 is registered in ClinicalTrials.gov with Precisis US, Inc. as lead sponsor.

NCT NCT07301346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07301346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EASEE® System Pivotal Study for the United States of America
Lead sponsor
Precisis US, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
November 1, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-resistant focal epilepsy